Literature DB >> 19445507

Asymmetric [4 + 3] cycloadditions between vinylcarbenoids and dienes: application to the total synthesis of the natural product (-)-5-epi-vibsanin E.

Brett D Schwartz1, Justin R Denton, Yajing Lian, Huw M L Davies, Craig M Williams.   

Abstract

The total synthesis of (-)-5-epi-vibsanin E (2) has been achieved in 18 steps. The synthesis combines the rhodium-catalyzed [4 + 3] cycloaddition between a vinylcarbenoid and a diene to rapidly generate the tricyclic core with an effective end game strategy to introduce the remaining side-chains. The [4 + 3] cycloaddition occurs by a cyclopropanation to form a divinylcyclopropane followed by a Cope rearrangement to form a cycloheptadiene. The quaternary stereogenic center generated in the process can be obtained with high asymmetric induction when the reaction is catalyzed by the chiral dirhodium complex, Rh(2)(S-PTAD)(4).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19445507      PMCID: PMC2717789          DOI: 10.1021/ja9019484

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  21 in total

1.  Unique strategy for the assembly of the carbon skeleton of guanacastepene A using an allenic Pauson-Khand-type reaction.

Authors:  Kay M Brummond; Dong Gao
Journal:  Org Lett       Date:  2003-09-18       Impact factor: 6.005

2.  Total synthesis of (-)-heptemerone B and (-)-guanacastepene E.

Authors:  Aubry K Miller; Chambers C Hughes; Joshua J Kennedy-Smith; Stefan N Gradl; Dirk Trauner
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

3.  A stereoselective route to guanacastepene A through a surprising epoxidation.

Authors:  Songnian Lin; Gregory B Dudley; Derek S Tan; Samuel J Danishefsky
Journal:  Angew Chem Int Ed Engl       Date:  2002-06-17       Impact factor: 15.336

4.  Enantioselective total synthesis of guanacastepene N using an uncommon 7-endo Heck cyclization as a pivotal step.

Authors:  Shin Iimura; Larry E Overman; Ralph Paulini; Armen Zakarian
Journal:  J Am Chem Soc       Date:  2006-10-11       Impact factor: 15.419

5.  Seven-membered vibsane-type diterpenes with a 5,10-cis relationship from Viburnum awabuki.

Authors:  Yoshiyasu Fukuyama; Hiroyuki Minami; Asami Matsuo; Kanako Kitamura; Mie Akizuki; Miwa Kubo; Mitsuaki Kodama
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-03       Impact factor: 1.645

6.  Exploring an expedient IMDA reaction approach to construct the guanacastepene core.

Authors:  Chuang-Chuang Li; Shuang Liang; Xin-Hao Zhang; Zhi-Xiang Xie; Jia-Hua Chen; Yun-Dong Wu; Zhen Yang
Journal:  Org Lett       Date:  2005-08-18       Impact factor: 6.005

7.  A total synthesis of guanacastepene C.

Authors:  Goverdhan Mehta; Kotapalli Pallavi; Jayant D Umarye
Journal:  Chem Commun (Camb)       Date:  2005-07-29       Impact factor: 6.222

8.  A convergent synthesis of the tricyclic architecture of the guanacastepenes featuring a selective ring fragmentation.

Authors:  William D Shipe; Erik J Sorensen
Journal:  Org Lett       Date:  2002-06-13       Impact factor: 6.005

9.  Isotope effects and the nature of selectivity in rhodium-catalyzed cyclopropanations.

Authors:  Daniel T Nowlan; Timothy M Gregg; Huw M L Davies; Daniel A Singleton
Journal:  J Am Chem Soc       Date:  2003-12-24       Impact factor: 15.419

10.  An expeditious Nazarov cyclization strategy toward the hydroazulene core of guanacastepene A.

Authors:  Pauline Chiu; Shuoliang Li
Journal:  Org Lett       Date:  2004-02-19       Impact factor: 6.005

View more
  26 in total

1.  Towards the Total Synthesis of 3-Hydroxyvibsanin E.

Authors:  Brett D Schwartz; Justin R Denton; Paul V Bernhardt; Huw M L Davies; Craig M Williams
Journal:  Synthesis (Stuttg)       Date:  2009-09-01       Impact factor: 3.157

2.  Controlling factors for C-H functionalization versus cyclopropanation of dihydronaphthalenes.

Authors:  Etienne Nadeau; Dominic L Ventura; Jonathan A Brekan; Huw M L Davies
Journal:  J Org Chem       Date:  2010-03-19       Impact factor: 4.354

3.  Reversal of the regiochemistry in the rhodium-catalyzed [4+3] cycloaddition between vinyldiazoacetates and dienes.

Authors:  Pablo E Guzmán; Yajing Lian; Huw M L Davies
Journal:  Angew Chem Int Ed Engl       Date:  2014-09-29       Impact factor: 15.336

Review 4.  Catalytic asymmetric cycloaddition reactions of enoldiazo compounds.

Authors:  Kostiantyn O Marichev; Michael P Doyle
Journal:  Org Biomol Chem       Date:  2019-04-24       Impact factor: 3.876

5.  Computationally guided stereocontrol of the combined C-H functionalization/Cope rearrangement.

Authors:  Yajing Lian; Kenneth I Hardcastle; Huw M L Davies
Journal:  Angew Chem Int Ed Engl       Date:  2011-08-30       Impact factor: 15.336

6.  Alkynoate synthesis through the vinylogous reactivity of rhodium(II) carbenoids.

Authors:  Damien Valette; Yajing Lian; John P Haydek; Kenneth I Hardcastle; Huw M L Davies
Journal:  Angew Chem Int Ed Engl       Date:  2012-07-16       Impact factor: 15.336

7.  Substrate-dependent divergent outcomes from catalytic reactions of silyl-protected enol diazoacetates with nitrile oxides: azabicyclo[3.1.0]hexanes or 5-arylaminofuran-2(3H)-ones.

Authors:  Xinfang Xu; Dmitry Shabashov; Peter Y Zavalij; Michael P Doyle
Journal:  J Org Chem       Date:  2012-06-04       Impact factor: 4.354

8.  Asymmetric Synthesis of Highly Functionalized Cyclopentanes by a Rhodium- and Scandium-Catalyzed Five-Step Domino Sequence.

Authors:  Brendan T Parr; Zhanjie Li; Huw M L Davies
Journal:  Chem Sci       Date:  2011-09-02       Impact factor: 9.825

Review 9.  Cycloaddition reactions of enoldiazo compounds.

Authors:  Qing-Qing Cheng; Yongming Deng; Marianne Lankelma; Michael P Doyle
Journal:  Chem Soc Rev       Date:  2017-08-29       Impact factor: 54.564

10.  Divergent outcomes of carbene transfer reactions from dirhodium- and copper-based catalysts separately or in combination.

Authors:  Xinfang Xu; Wen-Hao Hu; Peter Y Zavalij; Michael P Doyle
Journal:  Angew Chem Int Ed Engl       Date:  2011-10-06       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.